UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 18.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 95,477 shares of the semiconductor company's stock after buying an additional 14,552 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.29% of Silicon Laboratories worth $11,860,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Barclays PLC increased its holdings in shares of Silicon Laboratories by 23.4% during the third quarter. Barclays PLC now owns 70,568 shares of the semiconductor company's stock worth $8,157,000 after buying an additional 13,363 shares in the last quarter. KBC Group NV lifted its holdings in shares of Silicon Laboratories by 42.1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock worth $159,000 after buying an additional 379 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Silicon Laboratories by 1.8% during the 4th quarter. Pacer Advisors Inc. now owns 4,839 shares of the semiconductor company's stock valued at $601,000 after acquiring an additional 87 shares during the period. Caprock Group LLC acquired a new stake in shares of Silicon Laboratories during the 4th quarter worth approximately $376,000. Finally, Retirement Systems of Alabama increased its position in Silicon Laboratories by 0.5% during the 4th quarter. Retirement Systems of Alabama now owns 49,554 shares of the semiconductor company's stock worth $6,156,000 after purchasing an additional 231 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on SLAB. Susquehanna increased their price target on Silicon Laboratories from $100.00 to $110.00 and gave the stock a "neutral" rating in a report on Wednesday, May 14th. Needham & Company LLC restated a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Barclays lowered their target price on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 22nd. Benchmark reaffirmed a "buy" rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research report on Tuesday, May 27th. Finally, Stifel Nicolaus dropped their target price on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating on the stock in a research note on Thursday, April 17th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $126.50.
View Our Latest Research Report on SLAB
Insider Transactions at Silicon Laboratories
In related news, CEO Robert Matthew Johnson sold 5,879 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $131.20, for a total value of $771,324.80. Following the sale, the chief executive officer now owns 73,688 shares of the company's stock, valued at $9,667,865.60. This trade represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Christy Wyatt sold 546 shares of the company's stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total transaction of $57,029.70. Following the completion of the transaction, the director now owns 8,492 shares of the company's stock, valued at approximately $886,989.40. The trade was a 6.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,626 shares of company stock worth $1,509,319 over the last quarter. 1.60% of the stock is currently owned by insiders.
Silicon Laboratories Trading Up 0.2%
Shares of NASDAQ SLAB traded up $0.21 during midday trading on Wednesday, hitting $125.33. The company's stock had a trading volume of 333,248 shares, compared to its average volume of 338,062. Silicon Laboratories Inc. has a 12-month low of $82.82 and a 12-month high of $160.00. The firm has a market cap of $4.08 billion, a P/E ratio of -21.10 and a beta of 1.36. The business's 50 day moving average is $109.06 and its two-hundred day moving average is $122.51.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business had revenue of $177.71 million for the quarter, compared to analysts' expectations of $177.48 million. During the same period last year, the business earned ($0.92) EPS. The company's revenue was up 67.0% compared to the same quarter last year. On average, analysts predict that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Stories
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
